Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1962 1
1964 2
1965 20
1966 57
1967 62
1968 76
1969 48
1970 56
1971 69
1972 61
1973 60
1974 82
1975 98
1976 80
1977 117
1978 109
1979 117
1980 133
1981 164
1982 171
1983 279
1984 372
1985 404
1986 376
1987 408
1988 421
1989 535
1990 467
1991 492
1992 575
1993 593
1994 598
1995 653
1996 598
1997 609
1998 637
1999 665
2000 753
2001 808
2002 839
2003 1064
2004 1132
2005 1214
2006 1391
2007 1476
2008 1638
2009 1568
2010 1835
2011 2063
2012 2143
2013 2664
2014 2699
2015 2586
2016 2367
2017 2345
2018 2462
2019 1322
2020 28
Text availability
Article attribute
Article type
Publication date

Search Results

40,290 results
Results by year
Filters applied: . Clear all
Page 1
A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate Cancer.
Spratt DE, et al. Eur Urol 2018. PMID 28716370
We found that the benefit of hormone therapy varied by important prognostic factors, including pre-SRT prostate-specific antigen, Gleason grade, and surgical margin status. Our group then developed a framework on how best to utilize hormone therapy with SRT....
We found that the benefit of hormone therapy varied by important prognostic factors, including pre-SRT prostate-specific antigen, Gle …
Prostate cancer recurrence after Focal Therapy: Treatment options.
Hamid S, et al. Arch Esp Urol 2016 - Review. PMID 27416641
Focal therapy is a novel treatment option in localised prostate cancer with or without a visible lesion on MRI. Treatment for low to intermediate risk prostate cancer with focal therapy has demonstrated good short to medium term outcomes with fewer undesirable genitourinary side effects. ...In this paper we review the literature for treatment options in prostate cancer recurrence post focal therapy. We also cover the different definitions of failure agreed upon in previous consensus meetings, as well as their implications on future management focal therapy patients....
Focal therapy is a novel treatment option in localised prostate cancer with or without a visible lesion on MRI. Treatment for low to …
Management of Isolated Locoregional Recurrences in Breast Cancer: A Review of Local and Systemic Modalities.
Wadasadawala T, et al. Clin Breast Cancer 2017 - Review. PMID 28396099
Following a second breast conservation, partial breast irradiation has been seen to improve local control. Five-year overall survival with second breast conservation and radiotherapy is in the range of 76% to 100% with acceptable toxicities. ...Systemic therapy, in the form of chemotherapy and/or hormonal therapy in addition to adequate locoregional treatment, has shown to improve survival. ...
Following a second breast conservation, partial breast irradiation has been seen to improve local control. Five-year overall survival …
Local Recurrence of Extremity Soft Tissue Sarcoma.
Guerrero WM and Deneve JL. Surg Clin North Am 2016 - Review. PMID 27542648
Despite excellent limb-preservation therapies, approximately one-quarter of patients may eventually develop recurrence of disease. ...
Despite excellent limb-preservation therapies, approximately one-quarter of patients may eventually develop recurrence of disease. .. …
Management of local relapse after prostate cancer radiotherapy: Surgery or radiotherapy?
Hennequin C, et al. Cancer Radiother 2017 - Review. PMID 28890088
Isolated local relapse after prostate cancer radiotherapy corresponds to 40% of biochemical failure. The management of these relapses is not well defined. ...This is the same for stereotactic radiation therapy salvage treatment. A prospective trial of salvage brachytherapy (CAPRICUR) is now open in France and inclusion in this trial is recommended....
Isolated local relapse after prostate cancer radiotherapy corresponds to 40% of biochemical failure. The management of these relapses …
Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTEC
Sun XS, et al. Future Oncol 2018. PMID 29578359
Five-year survival rates are over 20% in selected patients who undergo metastasis-directed therapy by either surgery or stereotactic irradiation. ...
Five-year survival rates are over 20% in selected patients who undergo metastasis-directed therapy by either surgery or stereotactic …
Breast-conserving therapy for invasive carcinoma: diagnosis of local recurrence.
Rutgers EJ, et al. Neth J Surg 1991 - Review. PMID 1944988
Routine physical examination by surgeon or radiotherapist revealed local recurrence in 10 patients. Local recurrence was detected only by mammography in eight patients. ...In our experience, regular physical examination is the mainstay for the detection of local recurrence after breast conserving therapy. ...
Routine physical examination by surgeon or radiotherapist revealed local recurrence in 10 patients. Local recurrence
40,290 results
Jump to page
Feedback